ProQR Therapeutics NV (MEX:PRQR) Total Stockholders Equity : MXN1,745.8 Mil (As of Mar. 2025)

View and export this data going back to 2019. Start your Free Trial

What is ProQR Therapeutics NV Total Stockholders Equity?

ProQR Therapeutics NV's Total Stockholders Equity for the quarter that ended in Mar. 2025 was MXN1,745.8 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. ProQR Therapeutics NV's Book Value per Share for the quarter that ended in Mar. 2025 was MXN16.57. The ratio of a company's debt over equity can be used to measure how leveraged this company is. ProQR Therapeutics NV's Debt-to-Equity for the quarter that ended in Mar. 2025 was 0.21.

ProQR Therapeutics NV Total Stockholders Equity Historical Data

The historical data trend for ProQR Therapeutics NV's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ProQR Therapeutics NV Total Stockholders Equity Chart

ProQR Therapeutics NV Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Total Stockholders Equity

Get a 7-Day Free Trial

1,381.57

2,638.61

1,385.06

766.16

1,934.01

ProQR Therapeutics NV Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Total Stockholders Equity	Get a 7-Day Free Trial															628.15	647.89	545.95	1,934.01	1,745.80

ProQR Therapeutics NV (MEX:PRQR) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

ProQR Therapeutics NV's Book Value per Share for the quarter that ended in Mar. 2025 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(1745.803	-	0)	/	105.343
	=	16.57

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

ProQR Therapeutics NV's Debt-to-Equity for the quarter that ended in Mar. 2025 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(135.245	+	237.492)	/	1745.803
	=	0.21

ProQR Therapeutics NV Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of ProQR Therapeutics NV's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

ProQR Therapeutics NV Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ProQR Therapeutics NV (MEX:PRQR) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

PRQR:USA 0PQ:Germany

Address

Zernikedreef 9, Leiden, ZH, NLD, 2333 CK

Website

https://www.proqr.com

ProQR Therapeutics NV is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber congenital amaurosis type 10, and dystrophic epidermolysis bullosa. The only reportable segment of the company is the discovery and development of different, RNA-based therapeutics.